Sponge-Derived 24-Homoscalaranes as Potent Anti-Inflammatory Agents

Area of Science:

• Marine Natural Products Chemistry
• Medicinal Chemistry
• Immunology

Background:

• Scalarane-type sesterterpenoids are recognized for their anticancer properties.
• The anti-inflammatory potential of sesterterpenoids, particularly scalaranes, is largely unexplored.
• Marine sponges are a rich source of diverse bioactive secondary metabolites.

Purpose of the Study:

• To isolate and characterize new anti-inflammatory compounds from the marine sponge *Lendenfeldia* sp.
• To investigate the anti-neutrophilic activities of isolated scalarane derivatives.
• To identify novel therapeutic leads for inflammatory conditions.

Main Methods:

• Isolation of six new 24-homoscalaranes, designated lendenfeldaranes E-J (compounds 1-6).
• Structure elucidation using comprehensive spectroscopic analyses (NMR, MS).
• Determination of absolute configuration for compound 1 via electronic circular dichroism (ECD) calculations.
• Assessment of anti-inflammatory activity by measuring superoxide anion generation and elastase release inhibition.

Main Results:

• Six new scalarane-type sesterterpenoids, lendenfeldaranes E-J, were successfully isolated and characterized.
• Compounds 2 and 3 demonstrated significant reduction in superoxide anion generation.
• Compound 1 exhibited inhibitory effects on elastase release.
• Compounds 1, 2, and 3 were identified as the first reported anti-neutrophilic scalaranes.

Conclusions:

• The marine sponge *Lendenfeldia* sp. produces novel scalarane derivatives with potent anti-inflammatory properties.
• Lendenfeldaranes E-J represent a new class of anti-neutrophilic compounds.
• These findings highlight the therapeutic potential of marine-derived scalaranes in managing inflammatory diseases.